Finadyne Solution (50 ml)
Flunixin meglumine is a potent, non-steroidal, non-narcotic analgesic with anti-inflammatory, anti-endotoxic and anti-pyretic properties.In the horse, Finadyne Solution is indicated for the alleviation of inflammation and pain associated with musculo-skeletal disorders. It is also indicated for the... Read more
Flunixin meglumine is a potent, non-steroidal, non-narcotic analgesic with anti-inflammatory, anti-endotoxic and anti-pyretic properties.
In the horse, Finadyne Solution is indicated for the alleviation of inflammation and pain associated with musculo-skeletal disorders. It is also indicated for the alleviation of visceral pain associated with colic.
In cattle, Finadyne Solution is indicated for the control of acute inflammation associated with respiratory disease. It has also been shown to have some benefit in the treatment of experimental acute bovine pulmonary emphysema (Fog Fever).
In cattle, Finadyne may be used as adjunctive therapy in the treatment of acute mastitis.
In pigs, Finadyne Solution is indicated for use as an adjunctive therapy in the treatment of swine respiratory diseases.
Visit www.myvetmeds.co.uk / equine / joints-mobility-equine / finadyne-solution.htm
Product Description
About Finadyne Solution (50 ml)
Flunixin meglumine is a potent, non-steroidal, non-narcotic analgesic with anti-inflammatory, anti-endotoxic and anti-pyretic properties.
In the horse, Finadyne Solution is indicated for the alleviation of inflammation and pain associated with musculo-skeletal disorders. It is also indicated for the alleviation of visceral pain associated with colic.
In cattle, Finadyne Solution is indicated for the control of acute inflammation associated with respiratory disease. It has also been shown to have some benefit in the treatment of experimental acute bovine pulmonary emphysema (Fog Fever).
In cattle, Finadyne may be used as adjunctive therapy in the treatment of acute mastitis.
In pigs, Finadyne Solution is indicated for use as an adjunctive therapy in the treatment of swine respiratory diseases.
Please note: images are for illustration purposes only and pack sizes/strengths and new packaging styles may not be reflected in the image shown.
Directions For Use
Directions for Use
For use in equine musculo-skeletal disorders, the recommended dosage is 1 ml Finadyne Solution per 45 kg bodyweight (equivalent to 1.1 mg flunixin per kg) injected intravenously once daily for up to five days according to clinical response.
For use in equine colic, the recommended dosage is 1 ml Finadyne Solution per 45 kg bodyweight (equivalent to 1.1 mg flunixin per kg) by intravenous injection. Treatment may be repeated once or twice if colic recurs. The cause of colic should be determined and treated with concomitant therapy.
For the treatment of endotoxaemia or septic shock associated with gastric torsion and with other conditions in which circulation of blood to the gastrointestinal tract is impaired, the recommended dosage is 1 ml per 200 kg bodyweight (0.25 mg/kg) administered every 6?8 hours.For use in bovine acute inflammatory conditions, the recommended dosage is 2 ml Finadyne Solution per 45 kg bodyweight (equivalent to 2.2 mg flunixin per kg) injected intravenously and repeated as necessary at 24 hour intervals for up to 5 consecutive days. The cause of the acute inflammatory condition should be determined and treated with concomitant therapy.
For use in pigs, the recommended dosage is 2 ml Finadyne Solution per 45 kg bodyweight (equivalent to 2.2 mg flunixin/kg) once by intramuscular injection, in the neck, in conjunction with appropriate antimicrobial therapy. The injection volume should be limited to a maximum of 5 ml per injection site.
Active Ingredient
Finadyne Solution (50 ml) ingredients
A clear, light yellow, sterile solution for injection containing 50 mg flunixin, as flunixin meglumine BP (Vet), and 5 mg phenol Ph Eur as a preservative, per ml.
Uses
Side Effects
Side effects of Finadyne Solution (50 ml)
Do not exceed the stated dose or the duration of treatment.
Use is contra-indicated in animals suffering from cardiac, hepatic or renal disease, where there is the possibility of gastro-intestinal ulceration or bleeding, or where there is hypersensitivity to the product.
Do not administer to pregnant mares.
Do not administer to pregnant sows, gilts at mating and in breeding boars.
Special precautions for use in animals
Avoid intra-arterial injection.
Use in any animal less than 6 weeks of age or in aged animals may involve additional risk. If such use cannot be avoided, animals may require a reduced dosage and careful clinical management.
Do not use in hypovolaemic animals except in the case of endotoxaemia or septic shock.
It is preferable that NSAIDs which inhibit prostaglandin synthesis are not administered to animals undergoing general anaesthesia until fully recovered.
The cause of colic should be determined and treated with concurrent therapy.
The product should not be used in piglets weighing less than 6 kg.
Special Precautions to be taken by the Person Administering the Product to the Animal
Avoid contact with skin or eyes.
In case of skin contact, wash exposed area with water.
In case of eye contact, wash eyes thoroughly with clean water and seek medical advice.
Take care against accidental self injection.
Wash hands after use.
Special warning, interactions etc.
Non-steroidal, anti-inflammatory drugs are not permitted under the rules of Racing and under rules covering other competitive events.
The Royal College of Veterinary Surgeons has given advice to the Veterinary Profession regarding the use of anti-inflammatory drugs in competing horses. It states that "if a veterinarian recommends the discontinuation of any such drug not less than eight days before racing, he should feel sure that he has catered for all but the most exceptional case".
Do not exceed the recommended dose or duration of treatment.
Flunixin meglumine is a non-steroidal anti-inflammatory drug (NSAID). Untoward effects include gastro-intestinal irritation, ulceration and, in dehydrated or hypovolaemic animals, potential for renal damage.
In pigs, transient irritation may occur at the injection site, this resolves spontaneously within 14 days.
Do not administer other NSAIDs concurrently or within 24 hours of each other.
Some NSAIDs may be highly bound to plasma proteins and compete with other highly bound drugs which can lead to toxic effects.
Concurrent administration of potentially nephrotoxic drugs should be avoided.
The product may be used in pregnant and lactating cattle.
Do not use in pregnant mares or pregnant sows. Safety studies in pregnant mares and pregnant sows have not been conducted.
Overdosage studies in the target species have shown the product to be well-tolerated. Flunixin meglumine is a non-steroidal anti-inflammatory drug. Overdosage is associated with gastrointestinal toxicity. Concurrent use of nephrotoxic drugs should be avoided.
Withdrawal periods
Animals must not be slaughtered for human consumption during treatment.
Cattle: 5 days from the last treatment.
Horses: 7 days from the last treatment.
Pigs: 22 days from the last treatment.
Milk for human consumption must not be taken during treatment. Milk for human consumption may only be taken from cattle after 24 hours from the last treatment.
For animal treatment only. Keep out of the reach and sight of children.
Additional Data
Finadyne Solution (50 ml) specification
| Specification: | Detail: |
|---|---|
| Pack Size: | 50 ml |
| Brands: | Schering-plough |
| Product Form: | injection |
| External Link: | http://www.noahcompendium.co.uk/intervet_schering-plough/documents/S4096.html |
